LU-224332

N/A

Report date: 2025/03/21 17:40:00

Base Information

Drug NameLU-224332

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEndothelin receptor type A antagonistsEndothelin receptor type B antagonists

TargetsEndothelin receptor type BEndothelin receptor type A

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBasf

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBasf

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

ATC CodeN/A